These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 22537794

  • 1. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
    Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH.
    Biol Psychiatry; 2012 Sep 01; 72(5):405-13. PubMed ID: 22537794
    [Abstract] [Full Text] [Related]

  • 2. An FSCV Study on the Effects of Targeted Typical and Atypical DAT Inhibition on Dopamine Dynamics in the Nucleus Accumbens Shell of Male and Female Mice.
    Hersey M, Chen AY, Bartole MK, Anand J, Newman AH, Tanda G.
    ACS Chem Neurosci; 2023 Aug 02; 14(15):2802-2810. PubMed ID: 37466616
    [Abstract] [Full Text] [Related]

  • 3. Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.
    Keighron JD, Quarterman JC, Cao J, DeMarco EM, Coggiano MA, Gleaves A, Slack RD, Zanettini C, Newman AH, Tanda G.
    ACS Chem Neurosci; 2019 Apr 17; 10(4):2012-2021. PubMed ID: 30645944
    [Abstract] [Full Text] [Related]

  • 4. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.
    Mereu M, Chun LE, Prisinzano TE, Newman AH, Katz JL, Tanda G.
    Eur J Neurosci; 2017 Jan 17; 45(1):167-174. PubMed ID: 27545285
    [Abstract] [Full Text] [Related]

  • 5. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.
    Schmitt KC, Reith ME.
    PLoS One; 2011 Jan 17; 6(10):e25790. PubMed ID: 22043293
    [Abstract] [Full Text] [Related]

  • 6. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats.
    Hersey M, Mereu M, Jones CS, Bartole MK, Chen AY, Cao J, Hiranita T, Chun LE, Lopez JP, Katz JL, Newman AH, Tanda G.
    Eur J Neurosci; 2024 May 17; 59(10):2436-2449. PubMed ID: 38444104
    [Abstract] [Full Text] [Related]

  • 7. Distinct effects of (R)-modafinil and its (R)- and (S)-fluoro-analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats.
    Keighron JD, Giancola JB, Shaffer RJ, DeMarco EM, Coggiano MA, Slack RD, Newman AH, Tanda G.
    Eur J Neurosci; 2019 Aug 17; 50(3):2045-2053. PubMed ID: 30402972
    [Abstract] [Full Text] [Related]

  • 8. Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons.
    Avelar AJ, Cao J, Newman AH, Beckstead MJ.
    Neuropharmacology; 2017 Sep 01; 123():410-419. PubMed ID: 28625719
    [Abstract] [Full Text] [Related]

  • 9. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine.
    Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G.
    Biol Psychiatry; 2014 Nov 15; 76(10):802-9. PubMed ID: 24853388
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.
    Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH.
    J Pharmacol Exp Ther; 2009 May 15; 329(2):738-46. PubMed ID: 19197004
    [Abstract] [Full Text] [Related]

  • 11. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA, Newman AH, Eddington ND.
    J Pharmacol Exp Ther; 2007 Aug 15; 322(2):760-9. PubMed ID: 17519385
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
    Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K.
    JAMA; 2009 Mar 18; 301(11):1148-54. PubMed ID: 19293415
    [Abstract] [Full Text] [Related]

  • 15. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.
    Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL.
    Psychopharmacology (Berl); 2013 Sep 18; 229(2):307-21. PubMed ID: 23612854
    [Abstract] [Full Text] [Related]

  • 16. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.
    Loland CJ, Grånäs C, Javitch JA, Gether U.
    J Biol Chem; 2004 Jan 30; 279(5):3228-38. PubMed ID: 14597628
    [Abstract] [Full Text] [Related]

  • 17. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
    Zhang HY, Bi GH, Yang HJ, He Y, Xue G, Cao J, Tanda G, Gardner EL, Newman AH, Xi ZX.
    Neuropsychopharmacology; 2017 Aug 30; 42(9):1871-1883. PubMed ID: 28266501
    [Abstract] [Full Text] [Related]

  • 18. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
    Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, Gether U.
    Mol Pharmacol; 2008 Mar 30; 73(3):813-23. PubMed ID: 17978168
    [Abstract] [Full Text] [Related]

  • 19. Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity.
    Tanda G, Newman AH, Ebbs AL, Tronci V, Green JL, Tallarida RJ, Katz JL.
    J Pharmacol Exp Ther; 2009 Sep 30; 330(3):802-9. PubMed ID: 19483071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.